Literature DB >> 12691620

Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors.

Luke A J O'Neill1, Aisling Dunne, Michael Edjeback, Pearl Gray, Caroline Jefferies, Claudia Wietek.   

Abstract

Signal transduction processes activated by Toll-like receptors (TLRs) include the important transcription factor NF-kappaB and 2 MAP kinases, p38 and Jun N-terminal kinase. These signals ultimately give rise to increased expression of a multitude of pro-inflammatory proteins. Receptor-proximal proteins involved in signalling by all TLRs include the adapter MyD88, 3 IRAKs (IRAK-4, IRAK and IRAK-2), Tollip, Traf-6 and TAK-1. Differences between signals generated by TLRs are emerging, with both TLR4 and TLR2 signalling requiring an additional adapter termed MyD88-adapter-like (Mal; also known as TIRAP). MyD88 and Mal both have a homologous Toll/IL-1 receptor (TIR) domain although they differ in their N-termini, with MyD88 possessing a death domain. In addition, structural models reveal marked differences in surface charges which, when taken with surface charge differences between TLR2 and TLR4 TIR domains, may indicate that TLR4 but not TLR2 recruits Mal directly. Another difference is that Mal can become phosphorylated. Future studies on Mal will reveal specificities in signal transduction by different TLRs, which may ultimately provide molecular explanations for specificities in the innate immune response to infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691620     DOI: 10.1179/096805103125001351

Source DB:  PubMed          Journal:  J Endotoxin Res        ISSN: 0968-0519


  31 in total

1.  Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Authors:  Leah E Cole; Michelle H W Laird; Anna Seekatz; Araceli Santiago; Zhaozhao Jiang; Eileen Barry; Kari Ann Shirey; Katherine A Fitzgerald; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-11-04       Impact factor: 4.962

2.  Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

Authors:  Yan Li; Haijun Zhang; Hongmei Zhang; Alyssa K Kosturakis; Abdul Basit Jawad; Patrick M Dougherty
Journal:  J Pain       Date:  2014-04-19       Impact factor: 5.820

3.  9,10-dihydro-2,5-dimethoxyphenanthrene-1,7-diol, from Eulophia ochreata, inhibits inflammatory signalling mediated by Toll-like receptors.

Authors:  Praneel Datla; Mani Deepthi Kalluri; Khalander Basha; Akshaya Bellary; Rajendra Kshirsagar; Yogesh Kanekar; Shakti Upadhyay; Shiva Singh; Vikram Rajagopal
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Toll-like receptors are potential therapeutic targets in rheumatoid arthritis.

Authors:  Siamak Sandoghchian Shotorbani; Zhao-Liang Su; Hua-Xi Xu
Journal:  World J Biol Chem       Date:  2011-07-26

5.  Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediated microglial inflammation through regulation of the Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location.

Authors:  Tu Thi Ngoc Nguyen; Yong Min Kim; T Doohun Kim; Oanh Thi Tu Le; Jae Jin Kim; Ho Chul Kang; Hiroshi Hasegawa; Yasunori Kanaho; Ilo Jou; Sang Yoon Lee
Journal:  J Biol Chem       Date:  2013-01-07       Impact factor: 5.157

6.  Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge.

Authors:  Christopher W Cluff; Jory R Baldridge; Axel G Stöver; Jay T Evans; David A Johnson; Michael J Lacy; Valerie G Clawson; Vonnie M Yorgensen; Craig L Johnson; Mark T Livesay; Robert M Hershberg; David H Persing
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

7.  TREM-1 amplifies corneal inflammation after Pseudomonas aeruginosa infection by modulating Toll-like receptor signaling and Th1/Th2-type immune responses.

Authors:  Minhao Wu; Anping Peng; Mingxia Sun; Qiuchan Deng; Linda D Hazlett; Jin Yuan; Xialin Liu; Qianying Gao; Lianqiang Feng; Junfang He; Ping Zhang; Xi Huang
Journal:  Infect Immun       Date:  2011-05-09       Impact factor: 3.441

8.  Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.

Authors:  Jargalsaikhan Dagvadorj; Yoshikazu Naiki; Gantsetseg Tumurkhuu; Abu Shadat Mohammod Noman; Imtiaz Iftakhar-E-Khuda; Takayuki Komatsu; Naoki Koide; Tomoaki Yoshida
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

9.  Practical techniques for detection of Toll-like receptor-4 in the human intestine.

Authors:  Ryan Ungaro; Maria T Abreu; Masayuki Fukata
Journal:  Methods Mol Biol       Date:  2009

10.  Vibrio cholerae proteome-wide screen for immunostimulatory proteins identifies phosphatidylserine decarboxylase as a novel Toll-like receptor 4 agonist.

Authors:  Ann Thanawastien; Wagner R Montor; Joshua Labaer; John J Mekalanos; Sang Sun Yoon
Journal:  PLoS Pathog       Date:  2009-08-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.